Comparison of toxicity following single versus tandem autologous transplant regimens for pediatric medulloblastoma-Reference-Cited by-同舟云学术

Comparison of toxicity following single versus tandem autologous transplant regimens for pediatric medulloblastoma

Published:2022-01-26 Issue:4 Volume:26 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatric Transplantation

Author:

Plant‐Fox Ashley S.¹^ORCID,Ma Clement²,Al‐Sayegh Hasan³,Shyr Derek³,Lee Michelle A.⁴,Lehmann Leslie E.⁵,Chi Susan N.⁶

Affiliation:

1. Pediatric Neuro‐Oncology Division of Pediatric Oncology Ann and Robert H. Lurie Children's Hospital Chicago Illinois USA

2. Division of Pediatric Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

3. Harvard T.H. Chan School of Public Health Boston Massachusetts USA

4. Transplantation and Cellular Therapy Program Division of Hematology, Oncology, and Cellular Therapy Department of Pediatrics Children's Hospital at Montefiore Bronx New York USA

5. Pediatric Stem Cell Transplant Division of Pediatric Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

6. Pediatric Neuro‐Oncology Division of Pediatric Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.14229

Reference13 articles.

1. The treatment of medulloblastoma

2. Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I)

3. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results

4. Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy

5. Survival and Neurodevelopmental Outcome of Young Children With Medulloblastoma at St Jude Children's Research Hospital